Population Pharmacokinetics of Edoxaban in Chinese Patients With Non-Valvular Atrial Fibrillation

PHASE4RecruitingINTERVENTIONAL

Enrollment

120

Participants

Timeline

Start Date

March 30, 2022

Primary Completion Date

August 30, 2024

Study Completion Date

December 30, 2024

Conditions

Non-Valvular Atrial Fibrillation

Interventions

DRUG

Edoxaban

Eligible patients will receive Edoxaban tablet once a day for 12 weeks

Trial Locations (1)

RECRUITING

Fuwai Hospital, Chinese Academy of Medical Sciences, Beijing

All Listed Sponsors

collaborator

Chinese Academy of Medical Sciences, Fuwai Hospital

OTHER

lead

China National Center for Cardiovascular Diseases

OTHER_GOV